The 130th Annual Meeting of APHA

Abstract #52682

Martin T. Donahoe, MD FACP, Center for Ethics in Health Care, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098, N/A, anna.keller@apha.org

Learning Objectives:

• Understand how drugs are developed and tested
• Articulate the costs of development and testing, as well as how drugs are priced.
• Discuss industry sales, profits, and recent business trends.
• Assess the role of campaign donations and lobbying in drug regulation

Keywords: Drugs,

Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.